Clinical Trial Update: A Study to Evaluate the Safety, Immune Response, and Efficacy of Gardasil (V501, qHPV) in Mid-Adult Women (V501-019) [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating Gardasil (qHPV) in mid-adult women to assess safety, immune response, and efficacy; the trial is completed and results were posted in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer
• Cervical Intraepithelial Neoplasia
• Genital Warts
• Human Papillomavirus Infection

Drugs mentioned

• Gardasil (human papillomavirus vaccine)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Healthy Adult Female Participants, Prevention | Phase 3 | Status: COMPLETED | Results posted: 2010-02-01